-
1
-
-
73249114731
-
Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770
-
Van Goor F, Hadida S, Grootenhuis PD, et al. Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770. Proc Natl Acad Sci USA 2009, 106:18825-18830.
-
(2009)
Proc Natl Acad Sci USA
, vol.106
, pp. 18825-18830
-
-
Van Goor, F.1
Hadida, S.2
Grootenhuis, P.D.3
-
2
-
-
84862776940
-
Ivacaftor potentiation of multiple CFTR channels with gating mutations
-
Yu H, Burton B, Huang CJ, et al. Ivacaftor potentiation of multiple CFTR channels with gating mutations. J Cyst Fibros 2012, 11:237-245.
-
(2012)
J Cyst Fibros
, vol.11
, pp. 237-245
-
-
Yu, H.1
Burton, B.2
Huang, C.J.3
-
3
-
-
0003625836
-
-
Cystic Fibrosis Foundation, Bethesda, MD
-
Patient Registry 2012 Annual Data Report 2013, Cystic Fibrosis Foundation, Cystic Fibrosis Foundation, Bethesda, MD.
-
(2013)
Patient Registry 2012 Annual Data Report
-
-
-
4
-
-
84878970875
-
Efficacy and safety of ivacaftor in patients aged 6 to 11 years with cystic fibrosis with a G551D mutation
-
Davies JC, Wainwright CE, Canny GJ, et al. Efficacy and safety of ivacaftor in patients aged 6 to 11 years with cystic fibrosis with a G551D mutation. Am J Respir Crit Care Med 2013, 187:1219-1225.
-
(2013)
Am J Respir Crit Care Med
, vol.187
, pp. 1219-1225
-
-
Davies, J.C.1
Wainwright, C.E.2
Canny, G.J.3
-
5
-
-
80455162465
-
A CFTR potentiator in patients with cystic fibrosis and the G551D mutation
-
Ramsey BW, Davies J, McElvaney NG, et al. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N Engl J Med 2011, 365:1663-1672.
-
(2011)
N Engl J Med
, vol.365
, pp. 1663-1672
-
-
Ramsey, B.W.1
Davies, J.2
McElvaney, N.G.3
-
6
-
-
84911493956
-
Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation
-
De Boeck K, Munck A, Walker S, et al. Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation. J Cyst Fibros 2014, 13:674-680.
-
(2014)
J Cyst Fibros
, vol.13
, pp. 674-680
-
-
De Boeck, K.1
Munck, A.2
Walker, S.3
-
7
-
-
77953378283
-
Pathophysiology and therapeutic targets
-
Moss R Pathophysiology and therapeutic targets. Johns Hopkins Adv Studies Med 2010, 10:9-13.
-
(2010)
Johns Hopkins Adv Studies Med
, vol.10
, pp. 9-13
-
-
Moss, R.1
-
8
-
-
0029121023
-
Longitudinal evaluation of serum trypsinogen measurement in pancreatic-insufficient and pancreatic-sufficient patients with cystic fibrosis
-
Couper RT, Corey M, Durie PR, Forstner GG, Moore DJ Longitudinal evaluation of serum trypsinogen measurement in pancreatic-insufficient and pancreatic-sufficient patients with cystic fibrosis. J Pediatr 1995, 127:408-413.
-
(1995)
J Pediatr
, vol.127
, pp. 408-413
-
-
Couper, R.T.1
Corey, M.2
Durie, P.R.3
Forstner, G.G.4
Moore, D.J.5
-
9
-
-
0018421282
-
Quantitative evaluation of the development of the exocrine pancreas in cystic fibrosis and control infants
-
Imrie JR, Fagan DG, Sturgess JM Quantitative evaluation of the development of the exocrine pancreas in cystic fibrosis and control infants. Am J Pathol 1979, 95:697-708.
-
(1979)
Am J Pathol
, vol.95
, pp. 697-708
-
-
Imrie, J.R.1
Fagan, D.G.2
Sturgess, J.M.3
-
10
-
-
70349831005
-
Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening
-
Stick SM, Brennan S, Murray C, et al. Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening. J Pediatr 2009, 155:623-628.
-
(2009)
J Pediatr
, vol.155
, pp. 623-628
-
-
Stick, S.M.1
Brennan, S.2
Murray, C.3
-
11
-
-
84922259983
-
Digestive system dysfunction in cystic fibrosis: challenges for nutrition therapy
-
Li L, Somerset S Digestive system dysfunction in cystic fibrosis: challenges for nutrition therapy. Dig Liver Dis 2014, 46:865-874.
-
(2014)
Dig Liver Dis
, vol.46
, pp. 865-874
-
-
Li, L.1
Somerset, S.2
-
12
-
-
0036299705
-
Nutrition in patients with cystic fibrosis: a European Consensus
-
Sinaasappel M, Stern M, Littlewood J, et al. Nutrition in patients with cystic fibrosis: a European Consensus. J Cyst Fibros 2002, 1:51-75.
-
(2002)
J Cyst Fibros
, vol.1
, pp. 51-75
-
-
Sinaasappel, M.1
Stern, M.2
Littlewood, J.3
-
13
-
-
84884683771
-
Evolution of lung function during the first year of life in newborn screened cystic fibrosis infants
-
Nguyen TT, Thia LP, Hoo AF, et al. Evolution of lung function during the first year of life in newborn screened cystic fibrosis infants. Thorax 2014, 69:910-917.
-
(2014)
Thorax
, vol.69
, pp. 910-917
-
-
Nguyen, T.T.1
Thia, L.P.2
Hoo, A.F.3
-
14
-
-
84861892411
-
Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial
-
Rosenfeld M, Ratjen F, Brumback L, et al. Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial. JAMA 2012, 307:2269-2277.
-
(2012)
JAMA
, vol.307
, pp. 2269-2277
-
-
Rosenfeld, M.1
Ratjen, F.2
Brumback, L.3
-
15
-
-
47049115524
-
Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report
-
Farrell PM, Rosenstein BJ, White TB, et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr 2008, 153:S4-S14.
-
(2008)
J Pediatr
, vol.153
, pp. S4-S14
-
-
Farrell, P.M.1
Rosenstein, B.J.2
White, T.B.3
-
16
-
-
84976585919
-
-
(accessed Dec 2).
-
Kalydeco summary of product characteristics European Medicines Agency, (accessed Dec 2, 2015). http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002494/WC500130696.pdf.
-
(2015)
Kalydeco summary of product characteristics
-
-
-
17
-
-
12744281454
-
-
(accessed Dec 2).
-
Common Terminology Criteria for Adverse Events (CTCAE) version 4.0 National Cancer Institute, Cancer Therapy Evaluation ProgramCancer Therapy Evaluation Program, (accessed Dec 2, 2015). http://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm.
-
(2015)
Common Terminology Criteria for Adverse Events (CTCAE) version 4.0
-
-
-
18
-
-
34250190592
-
An official American Thoracic Society/European Respiratory Society statement: pulmonary function testing in preschool children
-
Beydon N, Davis SD, Lombardi E, et al. An official American Thoracic Society/European Respiratory Society statement: pulmonary function testing in preschool children. Am J Respir Crit Care Med 2007, 175:1304-1345.
-
(2007)
Am J Respir Crit Care Med
, vol.175
, pp. 1304-1345
-
-
Beydon, N.1
Davis, S.D.2
Lombardi, E.3
-
20
-
-
25144498760
-
Overweight and obesity in deltaF508 homozygous cystic fibrosis
-
Kastener-Cole D, Palmer CN, Ogston SA, Mehta A, Mukhopadhvay S Overweight and obesity in deltaF508 homozygous cystic fibrosis. J Pediatr 2005, 147:402-404.
-
(2005)
J Pediatr
, vol.147
, pp. 402-404
-
-
Kastener-Cole, D.1
Palmer, C.N.2
Ogston, S.A.3
Mehta, A.4
Mukhopadhvay, S.5
-
22
-
-
81855167481
-
Trypsin reduces pancreatic ductal bicarbonate secretion by inhibiting CFTR Cl(-channels and luminal anion exchangers
-
Pallagi P, Venglovecz V, Rakonczay Z, et al. Trypsin reduces pancreatic ductal bicarbonate secretion by inhibiting CFTR Cl(-channels and luminal anion exchangers. Gastroenterology 2011, 141:2228-2239.
-
(2011)
Gastroenterology
, vol.141
, pp. 2228-2239
-
-
Pallagi, P.1
Venglovecz, V.2
Rakonczay, Z.3
-
23
-
-
0034757380
-
Forced expiratory manoeuvres in children: do they meet ATS and ERS criteria for spirometry?
-
Arets HG, Brackel HJ, van der Ent CK Forced expiratory manoeuvres in children: do they meet ATS and ERS criteria for spirometry?. Eur Respir J 2001, 18:655-660.
-
(2001)
Eur Respir J
, vol.18
, pp. 655-660
-
-
Arets, H.G.1
Brackel, H.J.2
van der Ent, C.K.3
-
24
-
-
84861226870
-
Lung function distinguishes preschool children with CF from healthy controls in a multi-center setting
-
Kerby GS, Rosenfeld M, Ren CL, et al. Lung function distinguishes preschool children with CF from healthy controls in a multi-center setting. Pediatr Pulmonol 2012, 47:597-605.
-
(2012)
Pediatr Pulmonol
, vol.47
, pp. 597-605
-
-
Kerby, G.S.1
Rosenfeld, M.2
Ren, C.L.3
-
25
-
-
12744277962
-
Multiple-breath washout as a marker of lung disease in preschool children with cystic fibrosis
-
Aurora P, Bush A, Gustafsson P, et al. Multiple-breath washout as a marker of lung disease in preschool children with cystic fibrosis. Am J Respir Crit Care Med 2005, 171:249-256.
-
(2005)
Am J Respir Crit Care Med
, vol.171
, pp. 249-256
-
-
Aurora, P.1
Bush, A.2
Gustafsson, P.3
-
26
-
-
67349175293
-
Lung clearance index in the assessment of airways disease
-
Horsley A Lung clearance index in the assessment of airways disease. Respir Med 2009, 103:793-799.
-
(2009)
Respir Med
, vol.103
, pp. 793-799
-
-
Horsley, A.1
-
27
-
-
9644259076
-
Multiple breath inert gas washout as a measure of ventilation distribution in children with cystic fibrosis
-
Aurora P, Gustafsson P, Bush A, et al. Multiple breath inert gas washout as a measure of ventilation distribution in children with cystic fibrosis. Thorax 2004, 59:1068-1073.
-
(2004)
Thorax
, vol.59
, pp. 1068-1073
-
-
Aurora, P.1
Gustafsson, P.2
Bush, A.3
|